DALLAS: An Institute of Medical Research has undertaken a study using an immunoglobulin blood product to control and seemingly cure Alzheimer’s disease at a particular stage of the disease’s progression.
The study, using a blood product (where specific blood plasma proteins are extracted and formulated), showed the drug product can reduce brain atrophy and cognitive decline with patients who had an early, pre-dementia phase of Alzheimer’s disease.